When fat becomes dysfunctional, it can contribute to chronic conditions like: Type 2 diabetes Fatty liver disease PCOS and hormonal imbalance Chronic fatigue and inflammation Cardiovascular risk So, this isnt just about eating less or moving more. Its about understanding the biology behind behavior, and treating the person, not just the symptom
Soleiman designs GLP1 agonist protocols, including eligibility criteria, dose-escalation schedules, and follow-up intervals, rather than relying on generic weight-loss program templates
LaserTouch on Reels
It needs effective prevention and treatment
Erzen S, Tonin G, Jurisic Erzen D, Klen J
[DOI] [PubMed] [Google Scholar] 20.Lau D.C.W., Erichsen L., Francisco A.M., et al